Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NICE, C. M.
Right arrow Articles by STENSTROM, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NICE, C. M., JR.
Right arrow Articles by STENSTROM, K. W.
(Chest. 1955;28:529-536.)
© 1955 American College of Chest Physicians

Irradiation Therapy in Hodgkin's Disease of the Thorax

CHARLES M. NICE JR. M.D.1 and K. WILHELM STENSTROM Ph.D.1

1 The Department of Radiology, University of Minnesota Medical School.

The clinical staging of patients with Hodgkin's disease in general, as well as in those with thoracic Hodgkin's disease, seems to be the best factor to evaluate in outlining therapy and seems to be the factor best correlated with prognosis. [See Figures 1D and 1E in Source PDF.]

Intensive roentgen therapy, with an attempt to deliver a dosage of at least 2,000 roentgens in two weeks, is indicated in patients of stages I and II. In those with stage III disease, palliative roentgen therapy and clinical agents, such as nitrogen mustards and TEM, may give much symptomatic relief.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1955 by the American College of Chest Physicians.